EMERITUS
MENTORS A number of our past mentors, whilst having retired from regular mentoring, are available for specific and bespoke engagements where their broad experience can add real value for the next generation of leaders.

Sir Richard Sykes

Sir Richard Sykes

Experienced Chairman: FTSE 100, FTSE AIM, Stoxx Europe 50, Public Sector, Private Sector, Private Equity, Charities
Experienced CEO: Public Sector, Private Sector

  • 33 years of international senior leadership experience
  • Multi-industry knowledge in pharmaceuticals, healthcare, mining, private equity
  • Experience as a Nomination Committee Chair, Audit Committee member, Compensation Committee member, Compliance Committee member, Governance Committee member, Nomination Committee Chair

Current Positions

Sir Richard Sykes serves as Chairman of The Royal Institution of Great Britain, Chairman of King Edward VII’s Hospital, Chairman for Omnicyte Ltd and as a Non-Executive Director of PDS Biotechnology Corp. Sir Richard is also Chairman of The UK Stem Cell Foundation and on the International Advisory Board, of A*Star Biomedical Research Council, Singapore and Chancellor of Brunel University. 

Industry Knowledge

Sir Richard has previously held a number of senior appointments including Chairman and Chief Executive of Glaxo and Chairman and Chief Executive Glaxo Wellcome plc following the acquisition of Wellcome. He led the company through the formation of GlaxoSmithKline plc, where he was Chairman and CEO.

Sir Richard has also been Chairman of NetScientific plc, the Imperial College Healthcare NHS Trust, PDS Operating Corp, British Pharma Group, Frontier Smart Technology Group ltd, Medeus Pharma Limited, Vice Chairman at Swiss life sciences company Lonza Group AG, Deputy Chairman Eurasian Natural Resources Corp, a member of the President’s Committee of the Confederation of British Industry, a member of the UK Trade Policy Forum, Chairman of the Task Force for Inward Investment in the UK Pharmaceutical Industry, a member of the Advisory Committee for Human Genome Research, a member of the Council for Industry & Higher Education and member of DTI’s Strategy Board. He was also a Senior Independent Director of Rio Tinto plc, on the board of ContraFect Corp and a Non-Executive Chairman of Circassia Holdings Ltd.

Professor Dr Óscar Fanjul

Professor Dr Óscar Fanjul

Oscar Fanjul is Vice Chairman at LafargeHolcim and at Ferrovial. He remains Honorary Chairman of Repsol. Oscar Fanjul is currently the Vice Chairman of Omega Capital and is also a Non-Executive Director of Marsh & McLennan Companies Inc.

FULL BIO

Val Gooding CBE

Val Gooding CBE

Val Gooding is Senior Independent Director at Vodafone Group and Queen’s Trustee on the Board of Royal Botanical Gardens at Kew. Val was formerly CEO of Bupa, Chairman of Premier Farnell plc, and Chairman of Aviva Insurance UK.

FULL BIO

Dr André Lévy-Lang

Dr André Lévy-Lang

Dr André Lévy-Lang is the Founder and Chair of Institut Louis Bachelier, a research network, Chairman of Les Echos SAS and a Board member of the Institut Français des Relations Internationales. He was previously CEO of Paribas Group, Vice-Chairman of the Supervisory Board of Rothschild & Co, a Board member of Rothschild Martin Maurel, a member of the Executive Board of the French Banks Association and Chairman of the Finance Committee of the French Employers Association. 

FULL BIO

Hans Dalborg

Hans Dalborg

Hans Dalborg is currently Honorary Chairman of Nordea Bank. Hans has been Chairman of the Board of the Swedish Corporate Governance Board, Uppsala University, the Royal Swedish Academy of Engineering Sciences (IVA), ÅF Group and the hi-tech company IZettle.

FULL BIO